Literature DB >> 15018253

Medication error due to ambiguous labelling of a commercial product.

Henk-Jan Guchelaar1, Mathijs D Kalmeijer, Minke E P Jansen.   

Abstract

Medication errors may involve prescribing, dispensing, preparation and administration of drugs. We report a case in which an administration error occurred due to ambiguous labelling of a commercial drug. Tablets were packed in sets of two tablets per blister with the print on the blister 'Zelitrex 500', making the amount of drug per tablet unclear. A short survey among nurses and pharmacy technicians showed that the majority interpreted the strength of the tablets incorrectly. This case shows that, despite regulations for controlling and accepting labelling before marketing, ambiguous labelling may occur and can lead to medication errors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018253     DOI: 10.1023/b:phar.0000013517.84814.58

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  1 in total

1.  Toward defining and applying a higher standard of quality for medication use in the United States.

Authors:  H R Manasse
Journal:  Am J Health Syst Pharm       Date:  1995-02-15       Impact factor: 2.637

  1 in total
  1 in total

1.  Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries.

Authors:  Ramesh Sharma Poudel; Shakti Shrestha; Santosh Thapa; Bhupendra Kumar Poudel; Muniraj Chhetri
Journal:  J Pharm Policy Pract       Date:  2018-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.